These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9414035)

  • 1. Comparative study of the effects of indomethacin and NS-398, a selective cyclooxygenase 2 inhibitor, on duodenal bicarbonate secretion induced by luminal acidification in rats.
    Iwata K; Murakami N; Takase H; Saito T; Naruse T
    Jpn J Pharmacol; 1997 Oct; 75(2):191-4. PubMed ID: 9414035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of selective cyclooxygenase-2 inhibitors on alkaline secretory and mucosal ulcerogenic responses in rat duodenum.
    Hirata T; Ukawa H; Kitamura M; Takeuchi K
    Life Sci; 1997; 61(16):1603-11. PubMed ID: 9353169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
    Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines.
    Hara A; Yoshimi N; Niwa M; Ino N; Mori H
    Jpn J Cancer Res; 1997 Jun; 88(6):600-4. PubMed ID: 9263538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of endogenous prostaglandins and nitric oxide in gastroduodenal ulcerogenic responses induced in rats by hypothermic stress.
    Takeuchi K; Suzuki K; Araki H; Mizoguchi H; Sugamoto S; Umdeda M
    J Physiol Paris; 1999 Nov; 93(5):423-31. PubMed ID: 10674920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
    Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
    Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsteroidal anti-inflammatory drug-induced acute gastric injury in Helicobacter pylori gastritis in Mongolian gerbils.
    Takahashi S; Fujita T; Yamamoto A
    Eur J Pharmacol; 2000 Oct; 406(3):461-8. PubMed ID: 11040354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX and NOS isoforms involved in acid-induced duodenal bicarbonate secretion in rats.
    Takeuchi K; Kagawa S; Mimaki H; Aoi M; Kawauchi S
    Dig Dis Sci; 2002 Sep; 47(9):2116-24. PubMed ID: 12353866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats.
    Akiba Y; Maruta K; Narimatsu K; Said H; Kaji I; Kuri A; Iwamoto KI; Kuwahara A; Kaunitz JD
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G117-G128. PubMed ID: 28526687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins.
    Konturek PC; Brzozowski T; Konturek SJ; Taut A; Kwiecien S; Pajdo R; Sliwowski Z; Hahn EG
    Digestion; 1998; 59(4):284-97. PubMed ID: 9693198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation by nitric oxide of HCO3- secretion in bullfrog duodenum in vitro--roles of cyclooxygenase-1 and prostaglandins.
    Furukawa O; Kawauchi S; Mimaki H; Takeuchi K
    Med Sci Monit; 2000; 6(3):454-9. PubMed ID: 11208353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
    Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition.
    Xu H; Izon DJ; Loftin C; Spain LM
    Cell Immunol; 2001 Dec; 214(2):184-93. PubMed ID: 12088417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.
    Futaki N; Yoshikawa K; Hamasaka Y; Arai I; Higuchi S; Iizuka H; Otomo S
    Gen Pharmacol; 1993 Jan; 24(1):105-10. PubMed ID: 8482483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NSAID inhibition of RGM1 gastric monolayer wound re-epithelialization: comparison of selective Cox-2 versus non-selective Cox inhibitors.
    Giap AQ; Tarnawski A; Hoa NT; Akotia V; Ma TY
    Life Sci; 2002 May; 70(25):3029-37. PubMed ID: 12138016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of NS-398, a new nonsteroidal anti-inflammatory agent, on gastric ulceration and acid secretion in rats.
    Arai I; Hamasaka Y; Futaki N; Takahashi S; Yoshikawa K; Higuchi S; Otomo S
    Res Commun Chem Pathol Pharmacol; 1993 Sep; 81(3):259-70. PubMed ID: 8235061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.